Preferential use of the VH5-51 gene segment by the human immune response to code for antibodies against the V3 domain of HIV-1

Molecular Immunology

Volumn 46, Issue 5, 2009, Pages 917-926

  Gorny, Miroslaw K ^a   Wang, Xiao Hong ^b   Williams, Constance ^a   Volsky, Barbara ^a   Revesz, Kathy ^b   Witover, Bradley ^a   Burda, Sherri ^a   Urbanski, Mateusz ^a   Nyambi, Phillipe ^a,b   Krachmarov, Chavdar ^c   Pinter, Abraham ^c   Zolla Pazner, Susan ^a,b   Nadas, Arthur ^a   Choudhary, Alok ^d   Andrabi, Raiees ^d   Tranguch, Susanne ^d   Ryndak, Michelle ^d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d NONE

Author keywords

Anti HIV 1 antibodies; Human monoclonal antibodies; Immunoglobulin gene usage

Indexed keywords

ANTI V3 MONOCLONAL ANTIBODY; CD4 ANTIBODY; EPITOPE; GLYCOPROTEIN; GP41; IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; HEAVY CHAIN; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; IMMUNOGENETICS; MULTIGENE FAMILY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VH5 51 GENE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 59249105235     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.09.005     Document Type: Article

References (61)

1. Andris J.S., Johnson S., Zolla-Pazner S., and Capra J.D. Molecular characterization of five human anti-HIV-1 antibody heavy chains reveals extensive somatic mutation typical of an antigen-driven immune response. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 7783-7787
2. Andrus L., Prince A.M., Bernal I., McCormack P., Lee D.H., Gorny M.K., and Zolla-Pazner S. Passive immunization with a human immunodeficiency virus type-1 neutralizing monoclonal antibody in Hu-PBL-SCID mice: isolation of a neutralization escape variant. J. Infect. Dis. 177 (1998) 889-897
3. Bagley J., Dillon P.J., Rosen C., Robinson J., Sodroski J., and Marasco W.A. Structural characterization of broadly neutralizing human monoclonal antibodies against the CD4 binding site of HIV-1 gp120. Mol. Immunol. 31 (1994) 1149-1160
4. Barbas III C.F., Collet T.A., Amberg W., Roben P., Binley J.M., Hoekstra D., Cababa D., Jones T.M., Williamson R.A., and Pilkington G.R. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J. Mol. Biol. 230 (1993) 812-823
5. Baxendale H.E., and Goldblatt D. Correlation of molecular characteristics, isotype, and in vitro functional activity of human antipneumococcal monoclonal antibodies. Infect. Immun. 74 (2006) 1025-1031
6. Berberian L., Goodglick L., Kipps T.J., and Braun J. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261 (1993) 1588-1591
7. Boom R., Sol C.J., Salimans M.M., Jansen C.L., Wertheim-van Dillen P.M., and van der Noordaa J. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28 (1990) 495-503
8. Brezinschek H.P., Brezinschek R.I., and Lipsky P.E. Analysis of the heavy chain repertoire of human peripheral B cells using single-cell polymerase chain reaction. J. Immunol. 155 (1995) 190-202
9. Cardozo T., Kimura T., Philpott S., Weiser B., Burger H., and Zolla-Pazner S. Structural basis of co-receptor selectivity by the HIV-1 V3 loop. AIDS Res. Hum. Retroviruses 23 (2007) 415-426
10. Cavacini L.A., Emes C.L., Wisnewski A.V., Power J., Lewis G., Montefiori D., and Posner M.R. Functional and molecular characterization of human monoclonal antibody reactive with the immunodominant region of HIV type 1 glycoprotein 41. AIDS Res. Hum. Retroviruses 14 (1998) 1271-1280
11. Cook G.P., and Tomlinson I.M. The human immunoglobulin VH repertoire. Immunol. Today 16 (1995) 237-242
12. David D., Demaison C., Bani L., Zouali M., and Theze J. Selective variations in vivo of VH3 and VH1 gene family expression in peripheral B cell IgM, IgD and IgG during HIV infection. Eur. J. Immunol. 25 (1995) 1524-1528
13. David D., Goossens D., Desgranges C., Theze J., and Zouali M. Molecular characterization of human monoclonal antibodies specific for several HIV proteins: analysis of the VH3 family expression. Immunol. Lett. 47 (1995) 107-112
14. de Haard J.J., Kazemier B., Oudshoorn P., Boender P., van Gemen B., Koolen M.J., van der Groen G., Hoogenboom H.R., and Arends J.W. Selection of human anti-human immunodeficiency virus type 1 envelope single-chain antibodies from a peripheral blood cell-based phage repertoire. J. Gen. Virol. 79 (1998) 2883-2894
15. De Re V., De Vita S., Gasparotto D., Marzotto A., Carbone A., Ferraccioli G., and Boiocchi M. Salivary gland B cell lymphoproliferative disorders in Sjogren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas. Eur. J. Immunol. 32 (2002) 903-910
16. Delwart E.L., Shpaer E.G., Louwagie J., McCutchan F.E., Grez M., Rubsamen-Waigmann H., and Mullins J.I. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 Env genes. Science 262 (1993) 1257-1261
17. Ditzel H.J., Parren P.W., Binley J.M., Sodroski J., Moore J.P., Barbas III C.F., and Burton D.R. Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries. J. Mol. Biol. 267 (1997) 684-695
18. Emini E.A., Schleif W.A., Nunberg J.H., Conley A.J., Eda Y., Tokiyoshi S., Putney S.D., Matsushita S., Cobb K.E., Jett C.M., Eichberg J.W., and Murthy K.K. Prevention of HIV-1 infection in chimpanzees by gp120 V3 domain-specific monoclonal antibody. Nature 355 (1992) 728-730
19. Felgenhauer M., Kohl J., and Ruker F. Nucleotide sequences of the cDNAs encoding the V-regions of H- and L-chains of a human monoclonal antibody specific to HIV-1-gp41. Nucleic Acids Res. 18 (1990) 4927
20. Gorny M.K. Production of human monoclonal antibodies via fusion of Epstein-Barr virus-transformed lymphocytes with heteromyeloma. In: Celis J.E. (Ed). Cell Biology: A Laboratory Handbook vol. 2 (1994), Academic Press 276-281
21. Gorny M.K., Gianakakos V., Sharpe S., and Zolla-Pazner S. Generation of human monoclonal antibodies to HIV. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 1624-1628
22. Gorny M.K., Xu J.-Y., Gianakakos V., Karwowska S., Williams C., Sheppard H.W., Hanson C.V., and Zolla-Pazner S. Production of site-selected neutralizing human monoclonal antibodies against the third variable domain of the HIV-1 envelope glycoprotein. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 3238-3242
23. Gorny M.K., Conley A.J., Karwowska S., Buchbinder A., Xu J.Y., Emini E.A., Koenig S., and Zolla-Pazner S. Neutralization of diverse HIV-1 variants by an anti-V3 human monoclonal antibody. J. Virol. 66 (1992) 7538-7542
24. Gorny M.K., Xu J.-Y., Karwowska S., Buchbinder A., and Zolla-Pazner S. Repertoire of neutralizing human monoclonal antibodies specific for the V3 domain of HIV-1 gp120. J. Immunol. 150 (1993) 635-643
25. Gorny M.K., VanCott T.C., Hioe C., Israel Z.R., Michael N.L., Conley A.J., Williams C., Kessler II J.A., Chigurupati P., Burda S., and Zolla-Pazner S. Human monoclonal antibodies to the V3 loop of HIV-1 with intra- and interclade cross-reactivity. J. Immunol. 159 (1997) 5114-5122
26. Gorny M.K., Mascola J.R., Israel Z.R., VanCott T.C., Williams C., Balfe P., Hioe C., Brodine S., Burda S., and Zolla-Pazner S. A human monoclonal antibody specific for the V3 loop of HIV type 1 clade E cross-reacts with other HIV type 1 clades. AIDS Res. Hum. Retroviruses 14 (1998) 213-221
27. Gorny M.K., VanCott T.C., Williams C., Revesz K., and Zolla-Pazner S. Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins. Virology 267 (2000) 220-228
28. Gorny M.K., Williams C., Volsky B., Revesz K., Cohen S., Polonis V.R., Honnen W.J., Kayman S.C., Krachmarov C.P., Pinter A., and Zolla-Pazner S. Human monoclonal antibodies specific for conformation-sensitive epitopes of V3 neutralize HIV-1 primary isolates from various clades. J. Virol. 76 (2002) 9035-9045
29. Gorny M.K., Revesz K., Williams C., Volsky B., Louder M.K., Anyangwe C.A., Krachmarov C.P., Kayman S.C., Pinter A., Nadas A., Nyambi P.N., Mascola J.R., and Zolla-Pazner S. The V3 loop is accessible on the surface of most human immunodeficiency virus type 1 primary isolates and serves as a neutralization epitope. J. Virol. 78 (2004) 2394-2404
30. Gorny M.K., Stamatatos L., Volsky B., Revesz K., Williams C., Wang X.H., Cohen S., Staudinger R., and Zolla-Pazner S. Identification of a new quaternary neutralizing epitope on human immunodeficiency virus type 1 virus particles. J. Virol. 79 (2005) 5232-5237
31. Gorny M.K., Williams C., Volsky B., Revesz K., Wang X.H., Burda S., Kimura T., Koning F.A., Nadas A., Anyangwe C., Nyambi P., Krachmarov C., Pinter A., and Zolla-Pazner S. Cross-clade neutralizing activity of human anti-V3 monoclonal antibodies derived from the cells of individuals infected with non-B clades of HIV-1. J. Virol. 80 (2006) 6865-6872
32. Huang C.C., Venturi M., Majeed S., Moore M.J., Phogat S., Zhang M.Y., Dimitrov D.S., Hendrickson W.A., Robinson J., Sodroski J., Wyatt R., Choe H., Farzan M., and Kwong P.D. Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 2706-2711
33. Kayman S.C., Wu Z., Revesz K., Chen H., Kopelman R., and Pinter A. Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains. J. Virol. 68 (1994) 400-410
34. Krachmarov C., Pinter A., Honnen W.J., Gorny M.K., Nyambi P.N., Zolla-Pazner S., and Kayman S.C. Antibodies that are cross-reactive for human immunodeficiency virus type 1 clade A and clade B V3 domains are common in patient sera from Cameroon, but their neutralization activity is usually restricted by epitope masking. J. Virol. 79 (2005) 780-790
35. Kunert R., Ruker F., and Katinger H. Molecular characterization of five neutralizing anti-HIV type 1 antibodies: Identification of nonconventional D segments in the human monoclonal antibodies 2G12 and 2F5. AIDS Res. Hum. Retroviruses 14 (1998) 1115-1128
36. Kunert R., Wolbank S., Stiegler G., Weik R., and Katinger H. Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody. AIDS Res. Hum. Retroviruses 20 (2004) 755-762
37. Lewis C.M., Hollis G.F., Mark III G.E., Tung J.S., and Ludmerer S.W. Use of a novel mutagenesis strategy, optimized residue substitution, to decrease the off-rate of an anti-gp120 antibody. Mol. Immunol. 32 (1995) 1065-1072
38. Liu F., Bergami P.L., Duval M., Kuhrt D., Posner M., and Cavacini L. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120. AIDS Res. Hum. Retroviruses 19 (2003) 597-607
39. Lucas A.H., McLean G.R., Reason D.C., O'Connor A.P., Felton M.C., and Moulton K.D. Molecular ontogeny of the human antibody repertoire to the Haemophilus influenzae type B polysaccharide: expression of canonical variable regions and their variants in vaccinated infants. Clin. Immunol. 108 (2003) 119-127
40. Marasco W.A., Bagley J., Zani C., Posner M., Cavacini L., Haseltine W.A., and Sodroski J. Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody. J. Clin. Invest. 90 (1992) 1467-1478
41. Marks J.D., Tristem M., Karpas A., and Winter G. Oligonucleotide primers for polymerase chain reaction amplification of human immunoglobulin variable genes and design of family-specific oligonucleotide probes. Eur. J. Immunol. 21 (1991) 985-991
42. Moran M.J., Andris J.S., Matsumato Y., Capra J.D., and Hersh E.M. Variable region genes of anti-HIV human monoclonal antibodies: non-restricted use of the V gene repertoire and extensive somatic mutation. Mol. Immunol. 30 (1993) 1543-1551
43. Owens G.P., Winges K.M., Ritchie A.M., Edwards S., Burgoon M.P., Lehnhoff L., Nielsen K., Corboy J., Gilden D.H., and Bennett J.L. VH4 gene segments dominate the intrathecal humoral immune response in multiple sclerosis. J. Immunol. 179 (2007) 6343-6351
44. Sharon M., Kessler N., Levy R., Zolla-Pazner S., Gorlach M., and Anglister J. Alternative conformations of HIV-1 V3 loops mimic B hairpins in chemokines, suggesting a mechanism for coreceptor selectivity. Structure (Camb) 11 (2003) 225-236
45. Silberstein L.E., George A., Durdik J.M., and Kipps T.J. The V4-34 encoded anti-i autoantibodies recognize a large subset of human and mouse B-cells. Blood Cells Mol. Dis. 22 (1996) 126-138
46. Stanfield R.L., Gorny M.K., Zolla-Pazner S., and Wilson I.A. Crystal structures of HIV-1 neutralizing antibody 2219 in complex with three different V3 peptides reveal a new binding mode for HIV-1 cross-reactivity. J. Virol. 80 (2006) 6093-6105
47. Sun Y., Park M.K., Kim J., Diamond B., Solomon A., and Nahm M.H. Repertoire of human antibodies against the polysaccharide capsule of Streptococcus pneumoniae serotype 6B. Infect. Immun. 67 (1999) 1172-1179
48. Teng N.N., Lam K.S., Calvo Riera F., and Kaplan H.S. Construction and testing of mouse-human heteromyelomas for human monoclonal antibody production. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 7308-7312
49. Thali M., Furman C., Ho D.D., Robinson J., Tilley S., Pinter A., and Sodroski J. Discontinuous, conserved neutralization epitopes overlapping the CD4-binding region of human immunodeficiency virus type 1 gp120 envelope glycoprotein. J. Virol. 66 (1992) 5635-5641
50. Thali M., Moore J.P., Furman C., Charles M., Ho D.D., Robinson J., and Sodroski J. Characterization of conserved HIV-type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67 (1993) 3978-3988
51. Tiller T., Tsuiji M., Yurasov S., Velinzon K., Nussenzweig M.C., and Wardemann H. Autoreactivity in human IgG+ memory B cells. Immunity 26 (2007) 205-213
52. Traggiai E., Becker S., Subbarao K., Kolesnikova L., Uematsu Y., Gismondo M.R., Murphy B.R., Rappuoli R., and Lanzavecchia A. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med. 10 (2004) 871-875
53. van der Donk E.M., Schutten M., Osterhaus A.D., and van der Heijden R.W. Molecular characterization of variable heavy and light chain regions of five HIV type 1-specific human monoclonal antibodies. AIDS Res. Hum. Retroviruses 10 (1994) 1639-1649
54. Weitkamp J.H., Kallewaard N., Kusuhara K., Bures E., Williams J.V., LaFleur B., Greenberg H.B., and Crowe Jr. J.E. Infant and adult human B cell responses to rotavirus share common immunodominant variable gene repertoires. J. Immunol. 171 (2003) 4680-4688
55. Wisnewski A., Cavacini L., and Posner M. Human antibody variable region gene usage in HIV-1 infection. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 11 (1996) 31-38
56. Xu J.-Y., Gorny M.K., Palker T., Karwowska S., and Zolla-Pazner S. Epitope mapping of two immunodominant domains of gp41, the transmembrane protein of human immunodeficiency virus type 1, using ten human monoclonal antibodies. J. Virol. 65 (1991) 4832-4838
57. Zhang M.Y., Shu Y., Sidorov I., and Dimitrov D.S. Identification of a novel CD4i human monoclonal antibody Fab that neutralizes HIV-1 primary isolates from different clades. Antiviral Res. 61 (2004) 161-164
58. Zhong P., Burda S., Urbanski M., Kenfack H., Tongo M., Heyndrickx L., Nanfack A., Shang J., Agyingi L., Zolla-Pazner S., Zekeng L., and Nyambi P. HIV type 1 group M clades infecting subjects from rural villages in equatorial rain forests of Cameroon. J. Acquir. Immune Defic. Syndr. 31 (2002) 495-505
59. Zhong P., Burda S., Konings F., Urbanski M., Ma L., Zekeng L., Ewane L., Agyingi L., Agwara M., Saa Afane Z.E., Kinge T., Zolla-Pazner S., and Nyambi P. Genetic and biologic properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: further evidence of broad HIV-1 genetic diversity. AIDS Res. Hum. Rertroviruses 19 (2003) 1167-1178
60. Zolla-Pazner S., Gorny M.K., Nyambi P.N., VanCott T.C., and Nadas A. Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV. J. Virol. 73 (1999) 4042-4051
61. Zwick M.B., Labrijn A.F., Wang M., Spenlehauer C., Saphire E.O., Binley J.M., Moore J.P., Stiegler G., Katinger H., Burton D.R., and Parren P.W. Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J. Virol. 75 (2001) 10892-10905